Citation

A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study. HIV Clinical Trials. 2011. 12: 201-14. PMID: 22044856

Citation

Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study. Journal of Acquired Immune Deficiency Syndromes. 2011. 58: 253-60. PMID: 21857357

Citation

Kevin R. Robertson. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. Journal of Neurovirology. 2011. 17: 438-47. PMID: 21786076

Citation

Susan Brogly, Salvatore Dimauro, Russell B. Van Dyke, Paige L. Williams, Ali Naini, Daniel E. Libutti, Julia Choi, Michelle Chung, Mariana Gerschenson. Short Communication: Transplacental Nucleoside Analogue Exposure and Mitochondrial Parameters in HIV-Uninfected Children. AIDS. 2011. 27: 777-83. PMID: 21142587

Citation

Heather Jaspan, L. Myer, A. J. Flisher, Keren Middelkoop, D. Mark, Catherine Mathews, Linda-Gail Bekker. Sexual health, HIV risk, and retention in an adolescent HIV vaccine trial preparatory cohort. Journal of Adolescent Health. 2011. 49: 42-46. PMID: 21700155

Citation

Todd Hulgan, Richard H. Haubrich, Sharon A. Riddler, Pablo Tebas, Marylyn D. Ritchie, Grace McComsey, David W. Haas, Jeffrey A. Canter. European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS clinical trials group study A5142. AIDS. 2011. 25: 37-47. PMID: 20871389

Citation

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection. AIDS. 2011. 25: 2269-2278. PMID: 21941167

Citation

Kit Simpson, Rukmini Rajagopalan, Birgitta Dietz, Kevin W. Garren, Sharon A. Riddler, Richard H. Haubrich. Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data. Cost Effectiveness and Resource Allocation. 2011. 9: 5. PMID: 21548986

Citation

Jessica H. Brehm, Christina M. Lalama, Michael Hughes, Richard H. Haubrich, Sharon A. Riddler, Nicolas Sluis-Cremer, John W. Mellors. Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase. Journal of Acquired Immune Deficiency Syndromes. 2011. 56: 344-8. PMID: 21350368

Citation

Heather Ribaudo, Constance A. Benson, Yu (Evelyn) Zheng, Susan L. Koletar, Ann C. Collier, Judith J. Lok, Marlene Smurzynski, Ronald J. Bosch, Barbara Bastow, Jeffrey T. Schouten. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clinical Infectious Diseases. 2011. 52: 929-40. PMID: 21427402